TABLE 2.
Summary of metabolic pathways of potential biomarkers.
| Metabolic pathway | Total | Hits | Raw p | -log (p) | Impact | No. in Figure 6 |
|---|---|---|---|---|---|---|
| Pantothenate and CoA biosynthesis | 19 | 2 | 0.0073339 | 2.1347 | 0.00714 | e |
| Primary bile acid biosynthesis | 46 | 2 | 0.039973 | 1.3982 | 0.00805 | d |
| Aminoacyl-tRNA biosynthesis | 48 | 2 | 0.043228 | 1.3642 | 0 | — |
| Valine, leucine, and isoleucine biosynthesis | 8 | 1 | 0.055506 | 1.2557 | 0 | — |
| Taurine and hypotaurine metabolism | 8 | 1 | 0.055506 | 1.2557 | 0 | — |
| Nicotinate and nicotinamide metabolism | 15 | 1 | 0.10176 | 0.99242 | 0.1943 | a |
| Selenocompound metabolism | 20 | 1 | 0.13353 | 0.87443 | 0 | — |
| Alanine, aspartate, and glutamate metabolism | 28 | 1 | 0.18224 | 0.73936 | 0 | — |
| Glycine, serine, and threonine metabolism | 33 | 1 | 0.2114 | 0.67489 | 0 | — |
| Glycerophospholipid metabolism | 36 | 1 | 0.22844 | 0.64122 | 0.01736 | b |
| Arginine and proline metabolism | 38 | 1 | 0.23962 | 0.62048 | 0.01212 | c |
| Valine, leucine, and isoleucine degradation | 40 | 1 | 0.25064 | 0.60094 | 0 | — |